Texas and Connecticut Legalize State Medical Research into Psychedelics
Both states have enacted laws allowing research that private investors have been touting as treatment for mental health disorders.
Landwebs
Texas and Connecticut enacted laws this month allowing research into how psilocybin, the active ingredient in “magic mushrooms,” might help people with post-traumatic stress disorder, reports Bloomberg News. Governor Greg Abbott (R-Texas) on June 18 allowed a bill authorizing the study of psilocybin to become law without his signature. Connecticut Governor Ned Lamott (D) on June 7 signed a bill permitting psilocybin research in that state.
Magic mushroom research is already underway at Johns Hopkins, where experiments found that psilocybin-assisted therapy could help patients with major depressive disorder, and at the University of California, San Francisco, which has a Translational Psychedelic Research (TrPR) Program. Even before Connecticut and Texas acted, investors had taken notice of the pharmaceutical possibilities. At least three companies listed on U.S. stock exchanges have been touting psychedelics for the treatment of mental health disorders even though psilocybin and other hallucinogenic substances are illegal under federal law.
